Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug

The lawsuits come as Eli Lilly grapples with a shortage of Mounjaro in the U.S. due to skyrocketing demand.

Previous post Market Extra: Why Fed’s response to this key question could spark 5% stock-market pullback or ‘solid rally’
Next post : U.S. stocks log lowest close of September as Fed meeting looms